Viveve Medical, Inc. VIVE OTC

Other OTC • Healthcare • Medical - Devices • US • USD

Viveve Medical, Inc. (VIVE) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 5 Buy, 3 Hold, 2 Sell.

VIVE Analyst Ratings

Buy

Ratings

5 Buy

3 Hold

2 Sell

Based on 10 analysts giving stock ratings to Viveve Medical, Inc. in the past 3 months

Rating breakdown

Buy

5 50%

Hold

3 30%

Sell

2 20%

50%

Buy

5 analysts

30%

Hold

3 analysts

20%

Sell

2 analysts

People Also View

RPID

Rapid Micro Biosystems, Inc.

$2.35

+7.31%

HSDT

Helius Medical Technologies, Inc.

$1.94

-2.02%

CTSO

Cytosorbents Corporation

$0.59

+0.37%

SINT

Sintx Technologies, Inc.

Talis Biomedical Corporation

$2.84

+0.00%

HSCS

Heart Test Laboratories, Inc.

$1.98

+0.51%

Viveve Medical, Inc. VIVE OTC

VIVE Analyst Ratings

People Also View

Get Undervalued Stock Alerts